Castle Biosciences, Inc. (CSTL) vs Fulgent Genetics, Inc. (FLGT)
- Castle Biosciences, Inc. CSTL 31.96 −5.44%
- Fulgent Genetics, Inc. FLGT 19.81 −7.17%
Castle Biosciences, Inc. and Fulgent Genetics, Inc. are both Diagnostics & Research companies. Castle Biosciences, Inc. is the larger, with a market value of $1.0B against $587.2M — 1.8× the size. Fulgent Genetics, Inc. grew revenue faster over the last twelve months: 6.83% against 3.18%. Castle Biosciences, Inc. has the higher net margin (−5.43% vs −26.1%) and the higher return on invested capital (−9.40% vs −10.3%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 10 and Fulgent Genetics, Inc. on 8.
Valuation
Profitability
| Metric | CSTL | FLGT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 77.26% | 35.58% | 50.89% |
| Operating margin | (8.99%) | (37.75%) | (8.57%) |
| Net margin | (5.43%) | (26.05%) | (6.37%) |
| Free cash flow margin | (0.13%) | (32.04%) | 0.00% |
| Return on equity | (4.20%) | (8.01%) | (2.92%) |
| Return on assets | (3.51%) | (7.37%) | (6.71%) |
| Return on invested capital | (9.40%) | (10.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack